Treatment for spinal cord injury to tart clinical trial funded by CIRM
Asterias Biotherapeutics has been given approval by the FDA to begin a clinical trial of its stem cell therapy in patients with spinal cord injury. The California Institute for Regenerative Medicine, California’s stem cell agency, is funding the trial. August 27, 2014